In kasta oo jebinta ugu horeysa ee Cervarix aysan u muuqan in ay tahay mid u fiican in la ilaaliyo caabuqyada HPV- ga lagu kala qaado sida Gardasil ama Gardasil 9 , dhab ahaantii waa xulasho macquul ah oo tallaalka ah. Inkasta oo loogu talagalay inay ka hortagto laba nooc oo halis ah HPV (16 iyo 18) oo inta badan lala xiriiriyo kansarka ilma-mareenka (ugu yaraan haweenka Cawaanada ah ), marka la barbardhigo tallaalada kale ee lagu beegsanayo 4 ama 9 nooc, dhawr Daraasaduhu waxay bixiyeen caddaymo muujinaya in Cervarix uu dhab ahaantii awood u leeyahay inuu ka difaaco noocyo kala duwan oo HPV ah, oo ay ku jiraan, suurogal ahaan, HPV 31, 33, 35, 45, 52, iyo 58.
Si kastaba ha noqotee, Garadsil ka duwan, maahan in laga ilaaliyo mid ka mid ah noocyada halista hoose ee la xiriira burooyinka cawrada .
Cervarix kaligeed ma aha awoodda ay u leedahay in ay bixiso difaac iskutallaab ah oo ka dhan ah noocyada kale HPV. Gardasil sidoo kale waxay u muuqataa in ay leedahay awood u yeelashada difaac iskudhaf ah oo ka dhan ah noocyada kala duwan ee HPV, laakiin caddaynta ilaa taariikhda, inkastoo aan khilaaf ahayn, waxa ay soo jeedinaysaa in xadka difaacida iskutallaabtu aysan noqon karin sida weyn ee Cervarix. Intaa waxaa dheer, qaar ka mid ah cilmi-baarayaasha oo isbarbardhigaya awooda labada tallaal ee ka hortagaya noocyo kala duwan oo HPV ah ayaa helay cadaymo muujinaya in ilaalinta Cervarix laga yaabo inay sii dheeraato badbaadinta Gardasil.
Marka la eego, isku darka wadarta caddaymaha ayaa muujinaya in ikhtiyaarka tallaalka HPV uu yahay mid wanaagsan ... iyo in labadii tallaalba ay u egtahay in ay u dhiganto mid waxtar leh. Faa'iidada ugu weyn ee Gardasil waa awooda ay ka ilaaliso burooyinka xubnaha taranka iyo noocyada kala duwan ee kansarka .
Faa'iidada ugu muhiimsan ee Cervarix waa in laga yaabo inay bixiso difaac adag oo ka badan noocyo kala duwan oo kansar ah.
Oh, iyo sidoo kale mid ka mid ah faa'iidada kale ee Cervarix ee ka jirta Gardasil, ugu yaraan dad yar oo dadweynaha ah. Dhamaadkii 2013, Guddiga Yurub ayaa oggolaaday jadwalka qiyaasta daaweynta laba jeer, seddexda gabdhood, gabdhaha da'doodu tahay 9 ilaa 14.
Jadwalka 2-aad ee aan weli la ansixinin ee Mareykanka, laakiin haddii iyo marka ay tahay, taasi waxay noqon kartaa dhiirogelin xoog leh dadka qaarkood si ay u doortaan tallaalka Cervarix tallaalka tallaalka Gardasil. Haddii aad tahay qof necbaya irbado, ama haddii aad haysato welwel dhaqaale ama mid kale oo ku saabsan tallaalka, oo la dhameeyo kadib markii laba darajo ay noqon karto mid aad u soo jiidasho badan marka loo eego baahida loo qabo in lagu soo celiyo nambarka saddexaad.
Ilaha:
Bissett SL, Draper E, Myers RE, Godi A, Beddows S. Qalabka laf-dhabarka ee loo yaqaan 'Cross Cervarix®' ee tallaalka papillomavirus oo muujinaya noocyo kala duwan oo Alpha-9 ah. Tallaalka. 2014 Feb 26; 32 (10): 1139-46. doi: 10.1016 / j.vaccine 2014.01.008.
Einstein MH, Takacs P, Chatterjee A, Sperling RS, Chakhtoura N, Blatter MM, Lalezari J, David MP, Lin L, Struyf F, Dubin G. Isbarbardhigga immunogenicity muddada dheer iyo badbaadinta papillomavirus (HPV) -16 / Tallaalka HPV-6/11/16/18 ee haweenka caafimaadka qaba ee da'doodu u dhaxayso 18-45 sano: Falanqaynta dhammaadka-waxbarasho ee marxaladda kala-guurka heerka 3aad. Hum Vaccin Immunother. 2014; 10 (12): 3435-45. doi: 10.4161 / hv.36121.
Kohli M, Lawrence D, Haig J, Anonychuk A, Demarteau N. Samaynta saameynta farqiga u dhaxeeya xogta ilaalinta iskudhafka ee udhexeeya papillomavirus (HPV) -16/18 AS04-talaal-kicin ah iyo papillomavirus (HPV) -6 / 11/16/18 tallaalka Kanada. Caafimaadka Dadweynaha BMC. 2012 Oct 13; 12: 872. doi: 10.1186 / 1471-2458-12-872.
Malagón T, Drolet M, Boil MC, Franco EL, Jit M, Brisson J, Brisson M. Waxqabadka ka hortagga laba tallaal ee papillomavirus: dib u eegis nidaamsan iyo falanqayn metadal. Lancet Infect Dis. 2012 Oct; 12 (10): 781-9.
Nakalembe M, Banura C, Namujju PB, Mirembe FM. Heerarka ka hortagga HPV16 / 18 iyo HPV31 / 33/35/45/52/58 ee difaaca jirka ee AS04-ku-taliyeyaasha HPV16 / 18 ee la talaalay iyo kuwa aan la talaalin ee gabdhaha Ugandha ee da'doodu u dhaxayso 10-16 sano. Cudurka Kansarka Dhibbanaha. 2014 Sep 1; 9: 29. doi: 10.1186 / 1750-9378-9-29.
Toft L, Tolstrup M, Müller M, Sehr P, Bonde J, Storgaard M, Østergaard L, Søgaard OS. Isbarbardhiga tallaalka immunogenity ee tallaalka cervarix® iyo Gardasil® ee tallaalka papillomavirus ee loogu talagalay daawada unugyada aan HPV-31, HPV-33, iyo HPV-45 ee dadka waaweyn ee qaba HIV. Hum Vaccin Immunother. 2014 Maajo 10 (5): 1147-54. doi: 10.4161 / hv.27925.